Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Cerus Community
NasdaqGM:CERS Community
1
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
Cerus
Popular
Undervalued
Overvalued
Community Investing Ideas
Cerus
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Platelet Business And IFC Demand Will Open Global Markets
Key Takeaways Expansion in platelet business and demand for IFC are expected to drive significant revenue growth. Market penetration and international expansion efforts could enhance revenue through regulatory approvals and product innovations.
View narrative
US$4.25
FV
69.6% undervalued
intrinsic discount
12.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
CERS
CERS
Cerus
Your Fair Value
US$
Current Price
US$1.29
71.5% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-71m
322m
2015
2018
2021
2024
2025
2027
2030
Revenue US$321.7m
Earnings US$47.5m
Advanced
Set Fair Value